Douglas W. Shevlin
- Oncology
- Clinical Biochemistry top 5%
- Epidemiology
- Molecular Biology
- Endocrinology, Diabetes and Metabolism
- Co-authors
- Paul J. GoodfellowSamuel A. WellsWilliam S. TungDetlef K. BartschZahid KaleemO. KiskerJeffrey A. NortonDonald R. Graham
- Topics
- Cancer-related Molecular Pathways (5 papers)Thyroid Cancer Diagnosis and Treatment (5 papers)Genetic factors in colorectal cancer (3 papers)
- Journals
- JNCI Journal of the National Cancer InstituteAmerican Journal of Clinical PathologyGenes Chromosomes and Cancer
- Partner nations
- United StatesGermany
In The Last Decade
Douglas W. Shevlin
9 papers receiving 323 citations
Peers
Comparison fields: 5 of 53
- Oncology 145
- Clinical Biochemistry 94
- Epidemiology 76
- Molecular Biology 74
- Endocrinology, Diabetes and Metabolism 73
Countries citing papers authored by Douglas W. Shevlin
This map shows the geographic impact of Douglas W. Shevlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas W. Shevlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas W. Shevlin more than expected).
Fields of papers citing papers by Douglas W. Shevlin
This network shows the impact of papers produced by Douglas W. Shevlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas W. Shevlin. The network helps show where Douglas W. Shevlin may publish in the future.
Co-authorship network of co-authors of Douglas W. Shevlin
This figure shows the co-authorship network connecting the top 25 collaborators of Douglas W. Shevlin. A scholar is included among the top collaborators of Douglas W. Shevlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas W. Shevlin. Douglas W. Shevlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 105 | |
| 2 | 10 | |
| 3 | 4 | |
| 4 | 38 | |
| 5 | Allelotype of follicular thyroid carcinomas reveals genetic instability consistent with frequent nondisjunctional chromosomal loss. | 53 |
| 6 | 30 | |
| 7 | 19 | |
| 8 | 2 | |
| 9 | 68 |
About Douglas W. Shevlin
Douglas W. Shevlin is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Pathology and Forensic Medicine, having authored 9 papers that have together received 329 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers) and Genetic factors in colorectal cancer (3 papers). The work is most often cited by research in Clinical Biochemistry (94 citations), Applied Microbiology and Biotechnology (15 citations) and Oncology (145 citations). Douglas W. Shevlin has collaborated with scholars based in United States and Germany. Frequent co-authors include Paul J. Goodfellow, Samuel A. Wells, William S. Tung, Detlef K. Bartsch, Zahid Kaleem, O. Kisker, Jeffrey A. Norton, Donald R. Graham, Cheryl Drake and Charles D. Callahan. Their work appears in journals such as JNCI Journal of the National Cancer Institute, American Journal of Clinical Pathology and Genes Chromosomes and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.